Notes from the Field: Fungal Bloodstream Infections Associated with a Compounded Intravenous Medication at an Outpatient Oncology Clinic – New York City, 2016 (2016)

Government Record · Vasquez AM, Lake J, Ngai S, et al.; CDC MMWR 65(45):1274-1275 · November 18, 2016

Vasquez AM et al., 2016-11-18: CDC field report of four Exophiala dermatitidis bloodstream infections among oncology patients exposed to a compounded IV medication prepared at a single outpatient clinic.

two cases of Exophiala dermatitidis bloodstream infections among patients with malignancies who had received care from a single physician at an outpatient oncology facility

MMWR 65(45):1274, first paragraph

Vasquez AM et al., 2016-11-18: CDC field report of four Exophiala dermatitidis bloodstream infections among oncology patients exposed to a compounded IV medication prepared at a single outpatient clinic. Documents an outbreak from a compounded IV product prepared at an outpatient oncology clinic (a saline/heparin/vancomycin/ceftazidime IV flush solution), not home infusion or hydration fluids. 38 patients exposed, 17 infected per FDA's summary. Funder: CDC outbreak investigation; no COI applicable. Live cdc.gov URL returns 403 to command-line clients; the archived snapshot contains the quoted text.